EUSA Pharma To Present at the 39th Annual J.P. Morgan Healthcare Conference


HEMEL HEMPSTEAD, United Kingdom – 11th January 2021

EUSA Pharma (UK) Limited (“EUSA Pharma”), a global biopharmaceutical company, announced today that Lee Morley, Chief Executive Officer, EUSA Pharma will be presenting at the virtual 39th Annual J.P. Morgan Healthcare Conference on 11th January 2021 at 12:10 Eastern Time.

About EUSA Pharma
Founded in March 2015, EUSA Pharma is a world-class biopharmaceutical company focused on oncology and rare disease. The company is headquartered in Hemel Hempstead, England (UK), and has extensive commercial operations in the United States and Europe, alongside a direct presence in selected other markets across the globe. EUSA Pharma is led by an experienced management team with a strong record of building successful pharmaceutical companies, and it is supported by significant funding raised from leading life science investor EW Healthcare Partners. For more information, please visit

EUSA Media
Rebecca Kerr
+44 7909 703627

Information provided is for general background purposes and is not intended as a substitute for medical diagnosis or treatment by a trained professional. You should always consult your physician about any healthcare questions you may have, especially before trying a new medication diet, fitness program, or approach to healthcare issues.